Cutler Group LP Global Blood Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$32.4 - $68.18 $14,320 - $30,135	-442 Reduced 35.59%	800 $54,000
Q2 2022 Aug 04, 2022	SELL	$22.3 - $37.39 $363,378 - $609,270	-16,295 Reduced 92.92%	1,242 $39,000
Q1 2022 Apr 14, 2022	BUY	$25.68 - $35.59 $445,214 - $617,023	17,337 Added 8668.5%	17,537 $607,000
Q4 2021 Jan 18, 2022	SELL	$24.9 - $40.26 $24,900 - $40,260	-1,000 Reduced 83.33%	200 $5,000
Q3 2021 Oct 26, 2021	BUY	$25.48 - $37.34 $1,401 - $2,053	55 Added 4.8%	1,200 $30,000
Q2 2021 Jul 19, 2021	SELL	$32.46 - $43.42 $50,475 - $67,518	-1,555 Reduced 57.59%	1,145 $40,000
Q1 2021 Apr 26, 2021	SELL	$38.94 - $50.85 $86,252 - $112,632	-2,215 Reduced 45.07%	2,700 $110,000
Q4 2020 Jan 21, 2021	BUY	$37.65 - $63.77 $53,274 - $90,234	1,415 Added 40.43%	4,915 $212,000
Q3 2020 Oct 27, 2020	BUY	$52.76 - $74.49 $142,452 - $201,123	2,700 Added 337.5%	3,500 $192,000
Q4 2019 Feb 06, 2020	SELL	$45.7 - $81.86 $59,410 - $106,418	-1,300 Reduced 61.9%	800 $63,000
Q3 2019 Oct 28, 2019	SELL	$45.35 - $57.91 $63,490 - $81,074	-1,400 Reduced 40.0%	2,100 $101,000
Q2 2019 Aug 09, 2019	BUY	$52.6 - $63.29 $141,336 - $170,060	2,687 Added 330.5%	3,500 $184,000
Q1 2019 May 10, 2019	SELL	$39.99 - $53.48 $377,505 - $504,851	-9,440 Reduced 92.07%	813 $43,000
Q4 2018 Feb 05, 2019	SELL	$31.54 - $46.67 $23,560 - $34,862	-747 Reduced 6.79%	10,253 $420,000
Q3 2018 Nov 07, 2018	BUY	$38.0 - $51.1 $143,146 - $192,493	3,767 Added 52.08%	11,000 $418,000
Q2 2018 Aug 10, 2018	SELL	$38.7 - $50.15 $748,883 - $970,452	-19,351 Reduced 72.79%	7,233 $326,000
Q4 2017 Jan 17, 2018	BUY	$29.7 - $45.7 $779,832 - $1.2 Million	26,257 Added 8029.66%	26,584 $1.05 Million
Q3 2017 Oct 17, 2017	BUY	$25.1 - $31.05 $8,207 - $10,153	327	327 $10,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account